Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 47Pancreatic Neoplasms 43Neoplasm Metastasis 20Carcinoma, Hepatocellular 20Lung Neoplasms 15Ovarian Neoplasms 14Colonic Neoplasms 14Rectal Neoplasms 12Stomach Neoplasms 11Prostatic Neoplasms 11Melanoma 11Cholangiocarcinoma 11Carcinoma, Renal Cell 10Breast Neoplasms 10Sarcoma 8Lymphoma, Non-Hodgkin 8Glioma 8Carcinoma, Non-Small-Cell Lung 8Neuroblastoma 7Hepatoblastoma 7Esophageal Neoplasms 7Barrett Esophagus 7Anus Neoplasms 7Wilms Tumor 6Uterine Cervical Neoplasms 6Medulloblastoma 6Gastrointestinal Neoplasms 6Ependymoma 6Central Nervous System Neoplasms 6Adenocarcinoma Of Esophagus 6

Interventions

pembrolizumab 1paricalcitol 1X-Rays 1Taxes 1Specimen Handling 1Pancreatectomy 1Hemoglobins 1Gemcitabine 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Resectable Pancreatic Carcinoma × Specimen Handling × Gastrointestinal × Clear all
NCT05841706 2025-06-10

Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer

Jonsson Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated
1 enrolled
Gastrointestinal

Resectable Pancreatic Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡